Research Article
The Clinical Clues of Pulmonary Alveolar Proteinosis: A Report of 11 Cases and Literature Review
Table 3
Therapeutic evaluation of WLL.
| | Patient number | 1 | 2 | 4 | 5 | 7 | 8 | 10 | 11 |
| | Before WLL | | | | | | | | | | DLCO (%) | 44.0 | 24.2 | 22.4 | 28.7 | 46.5 | 50.4 | 36.5 | 41.7 | | PaO2 (mmHg) | 62.5 | 48.5 | 54.3 | 59.8 | 63.0 | 81 | 62.2 | 77.4 | | mMRC score | 2 | 3 | 3 | 2 | 1 | 1 | 3 | 2 | | WLL (left) | 9.74 L | NA | 10.9 L | — | 13 L | — | 12 L | 13 L | | WLL (right) | 9.8 L | NA | 9 L | 1.5 L | 13 L | 6 L | 15L | 12 L | | After WLL | | | | | | | | | | DLCO (%) | 45.0 | NA | 36.8 | 30.1 | 56.0 | 51.6 | 48.6 | 59.3 | | PaO2 (mmHg) | 63.2 | NA | 61.2 | 77.4 | 95.6 | 83.5 | 78.3 | 80.3 | | mMRC score | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
|
|
NA: not available; mMRC: modified British medical research council score for shortness of breath.
|
